121
Participants
Start Date
July 21, 2015
Primary Completion Date
November 24, 2016
Study Completion Date
November 24, 2016
Interferon beta-1a Nebuliser solution 48 μg/mL
Interferon beta-1a, 0,5 ml (24 μg, metered dose) once daily inhalation for 14 days
Placebo
Placebo solution for once daily inhalation for 14 days
Research Site, Ciudad Autonomade Buenos Aires
Research Site, Westmead
Research Site, New Lambton
Research Site, Woolloongabba
Research Site, Bedford Park
Research Site, Marseille
Research Site, Bucheon-si
Research Site, Dijon
Research Site, Málaga
Research Site, Marbella (Málaga)
Research Site, Pessac
Research Site, Montpellier
Research Site, Seville
Research Site, Valencia
Research Site, Jeonju
Research Site, Lyon
Research Site, Paris
Research Site, Bogotá
Research Site, Floridablanca
Research Site, Buenos Aires
Research Site, CABA
Research Site, Nueve de Julio
Research Site, Quilmes
Research Site, Bogotá
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Blackpool
Research Site, Bradford
Research Site, Lancaster
Research Site, Leeds
Research Site, Manchester
Research Site, Nottingham
Research Site, Southampton
Lead Sponsor
AstraZeneca
INDUSTRY